Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Cor.Sync
company
About
A complete solution for ischemic cardiovascular deseases diagnosis at the emergency care
- 1 - 10
Details
- Last Funding Type
- Pre-seed
- Last Funding Money Raised
- R$700K
- Industries
- Biotechnology,Health Care,Health Diagnostics,Life Science
- Founded date
- Oct 15, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Cor.Sync is a complete solution for ischemic cardiovascular deseases diagnosis at the emergency care, with a point of care device that measures troponin levels with lab accuracy in only 8 minutes, along with a clinical decision aid platform, that uses a machine learning algorithm to analyze the test result and provide a dashboard with insight to support evidence-based medicine.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
R$1.55M
Cor.Sync has raised a total of
R$1.55M
in funding over 2 rounds. Their latest funding was raised on
Mar 1, 2022 from a Pre-seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 1, 2022 | Pre-seed | R$850K | 1 |
DOMO Invest
|
— | Detail |
| May 10, 2021 | Pre-seed | R$700K | 1 |
DOMO Invest
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Cor.Sync is funded by 1 investors.
DOMO Invest
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
DOMO Invest
|
Yes | Pre-seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
